TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Corline Biomedical AB
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Turnover |
15,737
|
5,135
|
2,739 |
Financial expenses |
0
|
9
|
0 |
Earnings before taxes |
1,556
|
-5,033
|
-5,401 |
EBITDA |
1,594
|
-5,001
|
-5,390 |
Total assets |
68,015
|
73,921
|
43,196 |
Current assets |
24,055
|
32,589
|
7,959 |
Current liabilities |
4,807
|
6,855
|
4,632 |
Equity capital |
63,208
|
67,066
|
38,564 |
- share capital |
1,795
|
1,953
|
1,545 |
Employees (average) |
10
|
9
|
8 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Solvency |
92.9%
|
90.7%
|
89.3% |
Turnover per employee |
1,574
|
571
|
342 |
Profit as a percentage of turnover |
9.9%
|
-98.0%
|
-197.2% |
Return on assets (ROA) |
2.3%
|
-6.8%
|
-12.5% |
Current ratio |
500.4%
|
475.4%
|
171.8% |
Return on equity (ROE) |
2.5%
|
-7.5%
|
-14.0% |
Change turnover |
11,018
|
2,448
|
1,951 |
Change turnover % | 233% | 247% | |
Chg. No. of employees |
1
![]() |
1
|
-1 |
Chg. No. of employees % | 11% | -11% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.